[1]Yang Z, Zhang WY. Interpretation of guidelines for diagnosis and treatment of pregnancy induced hypertension (2020) [J]. Chinese Journal of Obstetrics and Gynecology, 2020,55 (6): 425-432.(in Chinese)
杨孜,张为远.《妊娠期高血压疾病诊治指南(2020)》解读[J].中华妇产科杂志,2020,55(6):425-432.
[2]Cheng L. Effect of different degrees of pregnancy induced hypertension syndrome on pregnancy outcome [J]. Journal of Mathematical Medicine, 2015, 28 (10): 1445-1446. (in Chinese)
程丽.不同程度妊娠高血压综合症对妊娠结局的影响[J].数理医药学杂志, 2015, 28(10): 1445-1446.
[3]Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2018, 39(34): 3165-3241.
[4]Lu CQ, Lin J, Yuan L, et al. Pregnancy induced hypertension and outcomes in early and moderate preterm infants[J]. Pregnancy Hypertens, 2018, 14: 68-71.
[5]Deng L, Fang BM. Clinical epidemiological analysis of hypertensive disorder complicating pregnancy[J]. Hainan Medical Journal, 2015, 26(17):2602-2603. (in Chinese)
邓莉,方碧梅.妊娠期高血压疾病的临床流行病学分析[J]. 海南医学, 2015, 26(17):2602-2603.
[6]Pu J. Changes in the composition of maternal death causes in China [J]. Journal of Practical Obstetrics and Gynecology, 2021,37 (3): 161-165. (in Chinese)
蒲杰.我国孕产妇死因构成的变迁[J].实用妇产科杂志,2021,37(3):161-165.
[7]Awamleh Z, Han VKM. Identification of miR-210-5p in human placentae from pregnancies complicated by preeclampsia and intrauterine growth restriction, and its potential role in the pregnancy complications[J]. Pregnancy Hypertens, 2020, 19: 159-168.
[8]Liu J, Li W, Wang YQ. Bibliometric analysis of international research hotspots of pregnancy induced hypertension [J]. China Maternal and Child Health Research, 2017,28 (3): 262-266. (in Chinese)
刘珏,李维,王永清.妊娠期高血压疾病国际研究热点的文献计量分析[J].中国妇幼健康研究,2017,28(3):262-266.
[9]El-Shal AS, Shalaby SM, Aly NM, et al. Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome[J]. Mol Biol Rep, 2013, 40(11): 6063-6073.
[10]Haddad S. Vitamin-D receptor (VDR) gene polymorphism (FokI) in Syrian healthy population[J]. Gene Reports, 2021, 23: 101083.
[11]Li XW, Li J, Zhu QY. Correlation between serum vitamin D level and vitamin D receptor gene polymorphism in pregnant women with preeclampsia [J]. Journal of Medical Research, 2021,50 (1): 104-108. (in Chinese)
李祥雯,李晶,朱启英.子痫前期孕妇血清维生素D水平与维生素D受体基因多态性的相关性[J].医学研究杂志,2021,50(1):104-108.
[12]Robinson CJ, Alanis MC, Wagner CL, et al. Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia[J]. Am J Obstet Gynecol, 2010, 203(4): 366. e1-6.
[13]Zhou WZh, Qu HM. Role of bioactive factors in the pathogenesis of pregnancy induced hypertension [J]. International Journal of Obstetrics and Gynecology, 2021,48 (4): 361-366. (in Chinese)
周文哲,曲洪美.生物活性因子在妊娠期高血压疾病发病机制中的作用[J].国际妇产科学杂志,2021,48(4):361-366.
[14]Shin JS, Choi MY, Longtine MS, et al. Vitamin D effects on pregnancy and the placenta[J]. Placenta, 2010, 31(12): 1027-1034.
[15]Cim N, Kurdoglu M, Ege S, et al. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia[J]. J Matern Fetal Neonatal Med, 2017, 30(13): 1602-1607.
[16]Wang Y, Liu RX, Liu H. Association of adiponectin gene polymorphisms with hypertensive disorder complicating pregnancy and disorders of lipid metabolism[J]. Genet Mol Res, 2015, 14(4): 15213-15223.
[17]Elhoseiny SM, Morgan DS, Rabie AM, et al. Vitamin D receptor (VDR) gene polymorphisms (FokI, BsmI) and their relation to vitamin D status in pediatrics βeta thalassemia major[J]. Indian J Hematol Blood Transfus, 2016, 32(2): 228-238.
[18]McGrath JJ, Saha S, Burne THJ, et al. A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations[J]. J Steroid Biochem Mol Biol, 2010, 121(1-2): 471-477.
[19]Purswani JM, Gala P, Dwarkanath P, et al. The role of vitamin D in pre-eclampsia: a systematic review[J]. BMC Pregnancy Childbirth, 2017, 17(1): 1-15.
[20]O’Callaghan KM, Kiely M. Systematic review of vitamin D and hypertensive disorders of pregnancy[J]. Nutrients, 2018, 10(3): 294.
[21]Rezavand N, Tabarok S, Rahimi Z, et al. The effect of VDR gene polymorphisms and vitamin D level on blood pressure, risk of preeclampsia, gestational age, and body mass index[J]. J Cell Biochem, 2019, 120(4): 6441-6448.
[22]Rezende VB, Sandrim VC, Palei AC, et al. Vitamin D receptor polymorphisms in hypertensive disorders of pregnancy[J]. Mol Biol Rep, 2012, 39(12): 10903-10906.
|